Key Points Non-GAAP EPS was ($0.13), missing the consensus estimate by $0.02 (non-GAAP), due to higher pre-commercialization spending. Research and development expenses fell 48.2% compared to Q2 2024, ...

Non-GAAP earnings per share for Q2 2025 beat estimates by 14.0%, rising to $6.02 (non-GAAP) and up 21% year over year (non-GAAP). Revenue increased 9% to $9.2 billion, exceeding analyst expectations ...

Key Points OJEMDA net product revenue surged 310% year over year to $33.6 million in Q2 2025, driving total quarterly revenue (GAAP) to $33.9 million but narrowly missed consensus expectations for ...

Balance Sheet: At June 30, 2025, Cumberland had approximately $68 million in total assets, including $16 million in cash and cash equivalents. Liabilities totaled $40 million, including $5 million on ...

Fox holds very attractive sports rights, and Fox News is the long-running leader in cable news viewership, giving Fox pricing power that helps it offset the decline in pay TV subscribers and buck the ...

Solid execution across corporate, clinical and commercial initiatives -- -- Several key milestones advance 5x30 path to growth -- <p ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2025 and updated ...

Accounting firms today are at a crossroads. While client demands, regulatory pressures, and workloads have evolved dramatically, the tools used to handle ...

Syndax Pharmaceuticals, Inc. ( NASDAQ: SNDX) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET ...

Good morning, and welcome to the Icahn Enterprises L.P. Second Quarter 2025 Earnings Call with Andrew Teno, President and CEO and and Ted Papapostolou, Chief Financial Officer; and Robert Flint, Chief ...

RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported ...

Many lawmakers claim the same-sex partnership bill erodes the institution of traditional marriage. LGBTQ activists, meanwhile ...